A phase I dose-escalation, pharmacokinetic, drug-drug interaction study to evaluate vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancer.
Phase of Trial: Phase I
Latest Information Update: 03 Nov 2015
At a glance
- Drugs Vinflunine (Primary) ; Erlotinib
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- 03 Nov 2015 New trial record